Recovery Times of Half Dose Sugammadex and Neostigmine for Rocuronium-induced Neuromuscular Blockade

Clinical trial NCT06794450 · RECRUITING

Trial details

NCT number: NCT06794450
Sponsor: Universitas Padjadjaran
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Neuromuscular Blocking Agents Reversal of Neuromuscular Blockade Recovery Time

Start date: 2024-11-05
Primary completion: 2025-02-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.